Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10055)
All Articles published online
|
Publishing Process of This Article
|
Dec 27, 2014 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kwak MS, Kim YJ. Occult hepatitis B virus infection. World J Hepatol 2014; 6(12): 860-869 [PMID: 25544873 DOI: 10.4254/wjh.v6.i12.860] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v6/i12/860.htm |
| Number | Citing Articles |
| 1 |
Diana Gabriela Iacob, Monica Luminos, Otilia Elisabeta Benea, Ana-Maria Tudor, Cristina Mihaela Olariu, Simona Alexandra Iacob, Simona Ruta. Liver fibrosis progression in a cohort of young HIV and HIV/ HBV co-infected patients: A longitudinal study using non-invasive APRI and Fib-4 scores. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.888050
|
| 2 |
Joanne E. F. Costa, Viviane M. S. Morais, Juliana P. Gonçales, Ana Anizia D. P. Medeiros, Haline Barroso, Adriana P. Compri, Lucila Fukasawa, Regina C. Moreira, Maria Rosângela C. D. Coêlho. Occult hepatitis B virus infection in patients with leprosy. Journal of Medical Virology 2019; 91(5): 775 doi: 10.1002/jmv.25374
|
| 3 |
Lihong Shen, Yun Zhang, Min Shi, Lijia Shao, Shengchun Feng, Weiting Li, Zhonggang Fang, Jun Yin, Tinghua Li. Performance evaluation of the MAGLUMI Hepatitis B virus surface antigen chemiluminescence immunoassay. Journal of Medical Virology 2024; 96(7) doi: 10.1002/jmv.29817
|
| 4 |
Fujiko Mitsumoto-Kaseida, Masayuki Murata, Koji Takayama, Kazuhiro Toyoda, Eiichi Ogawa, Norihiro Furusyo, Jun Hayashi. Prevalence and characteristics of occult hepatitis B virus infection in Japanese human immunodeficiency virus-infected patients. Journal of Infection and Chemotherapy 2020; 26(1): 28 doi: 10.1016/j.jiac.2019.06.003
|
| 5 |
R. A. A. Pondé. Molecular mechanisms underlying HBsAg negativity in occult HBV infection. European Journal of Clinical Microbiology & Infectious Diseases 2015; 34(9): 1709 doi: 10.1007/s10096-015-2422-x
|
| 6 |
Hui Liu, Shuxiang Chen, Xin Liu, Jinli Lou. Effect of S-region mutations on HBsAg in HBsAg-negative HBV-infected patients. Virology Journal 2024; 21(1) doi: 10.1186/s12985-024-02366-2
|
| 7 |
Chul S. Hyun, Seulgi Lee, William R. Ventura. The prevalence and significance of isolated hepatitis B core antibody (anti-HBc) in endemic population. BMC Research Notes 2019; 12(1) doi: 10.1186/s13104-019-4287-z
|
| 8 |
C. R. Seed, P. Kiely, V. C. Hoad, A. J. Keller. Refining the risk estimate for transfusion‐transmission of occult hepatitis B virus. Vox Sanguinis 2017; 112(1): 3 doi: 10.1111/vox.12446
|
| 9 |
Claudia Bozza, Marika Cinausero, Donatella Iacono, Fabio Puglisi. Hepatitis B and cancer: A practical guide for the oncologist. Critical Reviews in Oncology/Hematology 2016; 98: 137 doi: 10.1016/j.critrevonc.2015.10.017
|
| 10 |
Nam Hee Kim, Hong Joo Kim, Ji Hun Kang. Impact of hepatitis B virus infection on the risk of gallbladder polyps: a cohort study. The Korean Journal of Internal Medicine 2023; 38(6): 844 doi: 10.3904/kjim.2023.197
|
| 11 |
Hong Yongzhi, Xu Min, Yu Bo, Chen Pin, Shi Xueqiang. The correlation between renal transplantation and liver carcinoma: a meta-analysis. Oncotarget 2017; 8(40): 68928 doi: 10.18632/oncotarget.19456
|
| 12 |
Ting-Ya Kuo, Jerry Che-Jui Chang, Yin-Chu Chien, Chyi-Feng Jan. The seroepidemiology of isolated core antibody against hepatitis B among Taiwanese adults - A large hospital-based study. Journal of the Formosan Medical Association 2024; 123(6): 693 doi: 10.1016/j.jfma.2023.10.018
|
| 13 |
Alberto Enrico Maraolo, Ivan Gentile, Antonio Riccardo Buonomo, Biagio Pinchera, Guglielmo Borgia. Current evidence on the management of hepatitis B in pregnancy. World Journal of Hepatology 2018; 10(9): 585-594 doi: 10.4254/wjh.v10.i9.585
|
| 14 |
Neziha Yılmaz, Aydın Çifci, Mehmet Balcı, Salih Cesur, Seda Sabah özcan, S. Süha Şen, Reyhan Öztürk, Çiğdem Kader, Hasan Irmak, Mehmet İbiş, Laser Sanal. Frequency of occult hepatitis B and C infections in hemodialysis patients. Ortadoğu Tıp Dergisi 2018; 10(2): 174 doi: 10.21601/ortadogutipdergisi.324840
|
| 15 |
Agoritsa Varaklioti, Anna Kouramba, Panagiota Ioannidou, Olga Katsarou. Occult hepatitis B virus infection in Greek patients with congenital bleeding disorders. Infection, Genetics and Evolution 2017; 54: 397 doi: 10.1016/j.meegid.2017.07.012
|
| 16 |
María L. Hepatitis B Virus (HBV) and S-Escape Mutants: From the Beginning until Now. Journal of Human Virology & Retrovirology 2015; 2(3) doi: 10.15406/jhvrv.2015.02.00046
|
| 17 |
Liu Yang, Tingting Li, Wenmin Li, Xi Tang, Jinfeng Li, Ruiwen Long, Yongshui Fu, Jean-Pierre Allain, Chengyao Li. Occult Hepatitis B Virus Infection in Hyperlipidemia Patients. The Tohoku Journal of Experimental Medicine 2017; 241(4): 255 doi: 10.1620/tjem.241.255
|
| 18 |
Suellen dos Reis Araújo, Andreza Pinheiro Malheiros, Vânia Pinto Sarmento, Heloisa Marceliano Nunes, Pedro Eduardo Bonfim Freitas. Molecular investigation of occult hepatitis B virus infection in a reference center in Northern Brazil. The Brazilian Journal of Infectious Diseases 2022; 26(3): 102367 doi: 10.1016/j.bjid.2022.102367
|
| 19 |
Dong‐Ze Ji, Xiao‐Yu Pang, Dan‐Ting Shen, Shu‐Na Liu, Hemant Goyal, Hua‐Guo Xu. Global prevalence of occult hepatitis B: A systematic review and meta‐analysis. Journal of Viral Hepatitis 2022; 29(5): 317 doi: 10.1111/jvh.13660
|
| 20 |
Fatma Amer, Monkez M. Yousif, Heba Mohtady, Rania A. Khattab, Ergenekon Karagoz, Khan F.M. Ayaz, Noha M. Hammad. Surveillance and impact of occult hepatitis B virus, SEN virus, and torque teno virus in Egyptian hemodialysis patients with chronic hepatitis C virus infection. International Journal of Infectious Diseases 2020; 92: 13 doi: 10.1016/j.ijid.2019.12.011
|
| 21 |
Resat Ozaras, Bilgul Mete, Fehmi Tabak. Occult Hepatitis B and Risk of Reactivation After Hepatitis C Treatment With Direct-Acting Antivirals. Clinical Gastroenterology and Hepatology 2017; 15(4): 605 doi: 10.1016/j.cgh.2016.11.030
|
| 22 |
Oluwadamilola G. Osasona, Oluwatosin O. Oguntoye, Abiola O. Arowosaye, Lukman O. Abdulkareem, Moses O. Adewumi, Christian Happi, Onikepe Folarin. Patterns of hepatitis b virus immune escape and pol/rt mutations across clinical cohorts of patients with genotypes a, e and occult hepatitis b infection in Nigeria: A multi-centre study. Virulence 2023; 14(1) doi: 10.1080/21505594.2023.2218076
|
| 23 |
Tatiane Cinquini Moraes, Fabíola Souza Fiaccadori, Menira Souza, Tâmera Nunes Vieira Almeida, Marielton dos Passos Cunha, Ítalo de Araújo Castro, Divina das Dôres de Paula Cardoso. Hepatitis B virus infection among institutionalized mentally ill patients in Brazil. The Brazilian Journal of Infectious Diseases 2015; 19(6): 643 doi: 10.1016/j.bjid.2015.07.007
|
| 24 |
Shweta Bhatt. Induced Pluripotent Stem-cell Lines in the Clinic - Still a Long Road Ahead. Journal of Human Virology & Retrovirology 2015; 2(3) doi: 10.15406/jhvrv.2015.02.00044
|
| 25 |
Hao Liao, Yan Liu, Jianhong Chen, Weiping Ding, Xiaodong Li, Zhihui Xu, Yuan Yang, Rongjuan Chen, Lanlan Si, Xiaoyuan Xu, Jianxun Guo, Dongping Xu. Characterization of hepatitis B virus (HBV) preS/S gene mutations in blood donors with occult HBV infection in the Baoji area of North China. Transfusion 2017; 57(3pt2): 857 doi: 10.1111/trf.14046
|
| 26 |
Hao Wang, Min Wang, Jieting Huang, Ru Xu, Qiao Liao, Zhengang Shan, Yourong Zheng, Xia Rong, Xi Tang, Tingting Li, Wenjing Wang, Chengyao Li, Yongshui Fu. Novel hepatitis B virus surface antigen mutations associated with occult genotype B hepatitis B virus infection affect HBsAg detection. Journal of Viral Hepatitis 2020; 27(9): 915 doi: 10.1111/jvh.13309
|
| 27 |
Awa Abdul Carimo, Eduardo Samo Gudo, Cremildo Maueia, Nédio Mabunda, Lúcia Chambal, Adolfo Vubil, Ana Flora, Francisco Antunes, Nilesh Bhatt, Pierre Roques. First report of occult hepatitis B infection among ART naïve HIV seropositive individuals in Maputo, Mozambique. PLOS ONE 2018; 13(1): e0190775 doi: 10.1371/journal.pone.0190775
|
| 28 |
X. Wen, H. Su, Y. Wang, Z. Pu, J. Gao, Z. Ji, X. Yuan, X. Li, W. Zhang, L. Zhang, Y. Long, Y. Yan, Z. Shao. Prevalence and natural course of occult hepatitis B virus infection in residents of 2 communities of Wuwei City, Gansu Province, China. Journal of Viral Hepatitis 2018; 25(3): 281 doi: 10.1111/jvh.12805
|
| 29 |
Tayibe Bal, Yusuf Onlen. The prevalence of occult hepatitis B in chronic hepatitis C patients treated with interferon-based antiviral therapy. Arab Journal of Gastroenterology 2018; 19(1): 33 doi: 10.1016/j.ajg.2018.02.001
|
| 30 |
Carlo Saitta, Teresa Pollicino, Giovanni Raimondo. Occult Hepatitis B Virus Infection: An Update. Viruses 2022; 14(7): 1504 doi: 10.3390/v14071504
|
| 31 |
Ashish Goyal, Ranjit Chauhan. The dynamics of integration, viral suppression and cell-cell transmission in the development of occult Hepatitis B virus infection. Journal of Theoretical Biology 2018; 455: 269 doi: 10.1016/j.jtbi.2018.06.020
|
| 32 |
Ryu Watanabe, Tomonori Ishii, Hideo Harigae. Pretreatment Screening for Hepatitis B Virus Infection in Patients with Systemic Lupus Erythematosus. The Tohoku Journal of Experimental Medicine 2015; 237(1): 9 doi: 10.1620/tjem.237.9
|
| 33 |
Zohreh Azarkar, Masood Ziaee, Azadeh Ebrahimzadeh, Gholamreza Sharifzadeh, Davod Javanmard. Epidemiology, risk factors, and molecular characterization of occult hepatitis B infection among anti‐hepatitis B core antigen alone subjects. Journal of Medical Virology 2019; 91(4): 615 doi: 10.1002/jmv.25343
|
| 34 |
A. Akram, S. M. R. Islam, S. U. Munshi, S. Tabassum. Detection of Hepatitis B Virus DNA among Chronic and potential Occult HBV patients in resource‐limited settings by Loop‐Mediated Isothermal Amplification assay. Journal of Viral Hepatitis 2018; 25(11): 1306 doi: 10.1111/jvh.12931
|
| 35 |
Marina P. Oliveira, Márcia A. D. Matos, Ágabo M. C. Silva, Carmen L. R. Lopes, Sheila A. Teles, Marcos A. Matos, Natália Spitz, Natalia M. Araujo, Rosa M. S. Mota, Ligia R. F. S. Kerr, Regina M. B. Martins, Zhefeng Meng. Prevalence, Risk Behaviors, and Virological Characteristics of Hepatitis B Virus Infection in a Group of Men Who Have Sex with Men in Brazil: Results from a Respondent-Driven Sampling Survey. PLOS ONE 2016; 11(8): e0160916 doi: 10.1371/journal.pone.0160916
|
| 36 |
Philippe J. Zamor, Ashley M. Lane. Interpretation of HBV Serologies. Clinics in Liver Disease 2021; 25(4): 689 doi: 10.1016/j.cld.2021.06.012
|
| 37 |
Ahmed Azzam, Heba Khaled, Esraa S. El-kayal, Fathy A. Gad, Sarah Omar. Prevalence of occult hepatitis B virus infection in Egypt: a systematic review with meta-analysis. Journal of the Egyptian Public Health Association 2023; 98(1) doi: 10.1186/s42506-023-00138-4
|
| 38 |
Safae Elkochri, Mohamed Rida Tagajdid, Rachid Abi, Hicham Elannaz, Idriss Lahlou Amine. Hépatite B occulte : un diagnostic à ne pas méconnaître. Revue Francophone des Laboratoires 2018; 2018(502): 67 doi: 10.1016/S1773-035X(18)30151-5
|
| 39 |
Davod Javanmard, Arezoo Marjani, Mohammad Hadi Karbalaie Niya, Ahmad Tavakoli, Seyed Jalal Kiani, Maryam Fatemipour, Mahdieh Hoseyni, Farah Bokharaei-Salim, Mahshid Panahi, Ehsan Alborzi, Somayeh Sadat Hosseini Fakhr, Seyed Hamidreza Monavari. Molecular Investigation of Occult Hepatitis B Virus Infection Among Patients with Liver Cancers. International Journal of Cancer Management 2023; 16(1) doi: 10.5812/ijcm-137093
|
| 40 |
Hidetaka Matsuda, Katsushi Hiramatsu, Yu Akazawa, Takuto Nosaka, Yasushi Saito, Yoshihiko Ozaki, Ryoko Hayama, Kazuto Takahashi, Tatsushi Naito, Kazuya Ofuji, Masahiro Ohtani, Tomoyuki Nemoto, Yukio Hida, Hideki Kimura, Yoshihiro Soya, Yasunari Nakamoto. Genetic polymorphism and decreased expression of HLA class II DP genes are associated with HBV reactivation in patients treated with immunomodulatory agents. Journal of Medical Virology 2018; 90(4): 712 doi: 10.1002/jmv.25011
|
| 41 |
Catherine Freeland, Vivek Sreepathi, Richard W. Hass, Jonathan M. Fenkel, Jessie Torgersen, Kenneth Rothstein, Chari Cohen, Robert G. Gish. The importance of triple panel testing for hepatitis B and the burden of isolated anti-hepatitis B core antibodies within a community sample. Journal of Virus Eradication 2023; 9(4): 100358 doi: 10.1016/j.jve.2023.100358
|
| 42 |
Davod Javanmard, Mohammad Hasan Namaei, Mohammad Farahmand, Arash Ziaee, Elham Amini, Masood Ziaee. Molecular and serological characterization of occult hepatitis B virus infection among patients with hemophilia. Journal of Medical Virology 2019; 91(8): 1519 doi: 10.1002/jmv.25470
|
| 43 |
Ricardo Wagner de Almeida, Francisco Campello do Amaral Mello, Isabelle Vasconcelos Menegoy, Márcia Paschoal do Espírito Santo, Cléber Ferreira Ginuíno, Paulo Sérgio Fonseca de Sousa, Livia Melo Villar, Elisabeth Lampe, Lia Laura Lewis-Ximenez. Detection and molecular characterisation of a diagnosis escape variant associated with occult hepatitis B virus in Brazil. Memórias do Instituto Oswaldo Cruz 2017; 112(7): 485 doi: 10.1590/0074-02760160477
|
| 44 |
David J. Weber, William A. Rutala. Plotkin's Vaccines. 2018; : 1402 doi: 10.1016/B978-0-323-35761-6.00072-9
|
| 45 |
Vijeta Bajpai, Ekta Gupta, Aashish Chaudhary, Meenu Bajpai. Clinical relevance of hepatitis B core total antibody in the detection of occult hepatitis B infection in patients with liver disease and blood donors. Asian Journal of Transfusion Science 2021; 15(2): 256 doi: 10.4103/ajts.AJTS_77_18
|
| 46 |
Romina Salpini, Vincenzo Malagnino, Lorenzo Piermatteo, Tiziana Mulas, Mohammad Alkhatib, Rossana Scutari, Elisabetta Teti, Carlotta Cerva, Katia Yu La Rosa, Marta Brugneti, Ada Bertoli, Benedetta Rossi, Vera Holzmayer, Jeffrey Gersch, Mary Kuhns, Gavin Cloherty, Francesca Ceccherini-Silberstein, Carlo-Federico Perno, Marco Iannetta, Massimo Andreoni, Loredana Sarmati, Valentina Svicher. Cryptic HBV Replicative Activity Is Frequently Revealed in Anti-HBc-Positive/HBsAg-Negative Patients with HIV Infection by Highly Sensitive Molecular Assays, and Can Be Predicted by Integrating Classical and Novel Serological HBV Markers. Microorganisms 2020; 8(11): 1819 doi: 10.3390/microorganisms8111819
|
| 47 |
Tran Thanh Tung, Jürgen Schmid, Vu Xuan Nghia, Le Chi Cao, Le Thi Kieu Linh, Ikrormi Rungsung, Bui Tien Sy, Truong Nhat My, Nguyen Trong The, Nghiem Xuan Hoan, Christian G. Meyer, Heiner Wedemeyer, Peter G. Kremsner, Nguyen Linh Toan, Le Huu Song, C.-Thomas Bock, Thirumalaisamy P. Velavan. Low Risk of Occult Hepatitis B Infection among Vietnamese Blood Donors. Pathogens 2022; 11(12): 1524 doi: 10.3390/pathogens11121524
|
| 48 |
Xinyi Jiang, Le Chang, Ying Yan, Huimin Ji, Huizhen Sun, Yingzi Xiao, Shi Song, Kaihao Feng, Abudulimutailipu Nuermaimaiti, Lunan Wang. Role of S protein transmembrane domain mutations in the development of occult hepatitis B virus infection. Emerging Microbes & Infections 2022; 11(1): 2184 doi: 10.1080/22221751.2022.2114849
|
| 49 |
Li-Ping Hu, De-Ping Liu, Qin-Yan Chen, Tim J. Harrison, Xiang He, Xue-Yan Wang, Hai Li, Chao Tan, Qing-Li Yang, Kai-Wen Li, Zhong-Liao Fang, Tatsuo Kanda. Occult HBV Infection May Be Transmitted through Close Contact and Manifest as an Overt Infection. PLOS ONE 2015; 10(10): e0138552 doi: 10.1371/journal.pone.0138552
|
| 50 |
Pranatharthi H. Chandrasekar, Miriam T. Levine. Occult Hepatitis B Virus Reactivation in a Seronegative Stem Cell Transplant Recipient. Infectious Diseases in Clinical Practice 2017; 25(2): 97 doi: 10.1097/IPC.0000000000000472
|
| 51 |
Ji Yun Lee, Sung Hee Lim, Min‐Young Lee, Haesu Kim, Dong Hyun Sinn, Geum‐Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Chul Won Jung, Jun Ho Jang, Won Seog Kim, Seok Jin Kim, Kihyun Kim. Hepatitis B reactivation in multiple myeloma patients with resolved hepatitis B undergoing chemotherapy. Liver International 2015; 35(11): 2363 doi: 10.1111/liv.12838
|
| 52 |
Shan-Shan Wu, Quan-Yuan Shan, Wen-Xuan Xie, Bin Chen, Yang Huang, Yu Guo, Xiao-Yan Xie, Ming-De Lu, Bao-Gang Peng, Ming Kuang, Shun-Li Shen, Wei Wang. Outcomes after hepatectomy of patients with positive HBcAb Non-B Non-C hepatocellular carcinoma compared to overt hepatitis B virus hepatocellular carcinoma. Clinical and Translational Oncology 2020; 22(3): 401 doi: 10.1007/s12094-019-02141-8
|
| 53 |
Jiaze Chen, Jinfang Ma, Xueqin Han, Yongxin Zhou, Baiheng Xie, Furong Huang, Li Li, Yuanpeng Li. Rapid detection of hepatitis B virus DNA level based on interval‐point data fusion of infrared spectra. Journal of Biophotonics 2023; 16(3) doi: 10.1002/jbio.202200251
|
| 54 |
R. Huang, X. Yan, J. Xia, J. Wang, C. Wu. Letter: hepatitis B virus reactivation in patients with chronic hepatitis C during direct‐acting anti‐viral therapy. Alimentary Pharmacology & Therapeutics 2017; 45(12): 1558 doi: 10.1111/apt.14080
|
| 55 |
Nathália Alves Araujo de Almeida, Vanessa Salete de Paula. Occult Hepatitis B virus (HBV) infection and challenges for hepatitis elimination: A literature review. Journal of Applied Microbiology 2022; 132(3): 1616 doi: 10.1111/jam.15351
|
| 56 |
Branko Borojevic, Ayushi Chauhan, Scott Patterson. Liver failure from delayed hepatitis B reactivation in anti-HBc-positive patient following rituximab for B-cell lymphoma. BMJ Case Reports 2021; 14(7): e243526 doi: 10.1136/bcr-2021-243526
|
| 57 |
Yurong Zou, Sipei Chen, Yiyuan Cui, Yang Zou. M133S mutation possibly involve in the ER stress and mitophagy pathway in maintenance hemodialysis patients with occult hepatitis B infection. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-64943-3
|
| 58 |
C. Trigo, P. E. A. A. do Brasil, M. J. M. Costa, L. de Castro. Occult hepatitis B virus infection: clinical implications in tuberculosis treatment. Journal of Viral Hepatitis 2016; 23(12): 1027 doi: 10.1111/jvh.12583
|
| 59 |
M. Sh. Khubutiya, S. A. Solonin, M. A. Godkov. THE PROBLEMS OF PROVIDING INFECTIOUS DISEASE SAFETY FOR ORGAN AND TISSUE DONATION BY SCREENING BLOOD-BORNE VIRAL INFECTIONS. Russian Journal of Transplantology and Artificial Organs 2016; 18(1): 83 doi: 10.15825/1995-1191-2016-1-83-90
|
| 60 |
Ali Mussa, Nor Hayati Ismail, Nazmul Huda Syed, Mustafa Talib, Alaa Siddig, Rosline Hassan, Rohimah Mohamud, Nik Haszroel Hysham Nik Hashim. Immune response to occult hepatitis B virus infection among hemodialysis patients: A review. The Microbe 2024; 5: 100176 doi: 10.1016/j.microb.2024.100176
|
| 61 |
Hao Wang, Fenfang Liao, Junmo Xie, Wenbo Gao, Min Wang, Jieting Huang, Ru Xu, Qiao Liao, Zhengang Shan, Yourong Zheng, Xia Rong, Chengyao Li, Yongshui Fu. E2 Site Mutations in S Protein Strongly Affect Hepatitis B Surface Antigen Detection in the Occult Hepatitis B Virus. Frontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.664833
|
| 62 |
|
| 63 |
Junichi Muraishi, Michihiko Shibata, Yuichi Honma, Masaaki Hiura, Shintaro Abe, Masaru Harada. Reactivation of Occult Hepatitis B Virus Infection 27 Months after the End of Chemotherapy Including Rituximab for Malignant Lymphoma. Internal Medicine 2017; 56(15): 1967 doi: 10.2169/internalmedicine.56.8233
|
| 64 |
Xichao Mo, Xuwen Xu, Zuning Ren, Junjie Guan, Jie Peng. Patients with tuberculous meningitis and hepatitis B co-infection have increased risk for antituberculosis drug-induced liver injury and poor outcomes. Infectious Diseases 2020; 52(11): 793 doi: 10.1080/23744235.2020.1788223
|
| 65 |
David J. Weber, Erica S. Shenoy. Plotkin's Vaccines. 2023; : 1469 doi: 10.1016/B978-0-323-79058-1.00072-4
|
| 66 |
Marc G. Ghany, Naveen Gara. Schiff's Diseases of the Liver. 2017; : 584 doi: 10.1002/9781119251316.ch24
|